Russell Dahl, PhD

CEO and founder of Neurodon.

Russell is the CEO and scientific founder of Neurodon. Previously, he led all small molecule research at Celladon, where he was responsible for progressing a diverse small molecule pipeline into the clinic. He started his career in the industry at Agouron Pharmaceuticals, progressing through positions of increasing responsibility at DuPont Pharmaceuticals, BMS, Vertex, and Kemia. During his tenure in the industry, he contributed to 13 molecules reaching advanced tox studies with 6 entering clinical trials.

Russell has also been involved in many successful biotech startups as a founder or advisor, having been directly involved in raising over $500M in funding including non-dilutive capital and 2 successful IPOs. His experience spans all phases of development and he has contributed to several IND filings and regulatory approvals. Russell has co-authored over 80 scientific publications and is an inventor on over 50 patent applications.

He is a former Professor of Neuroscience and Medicinal Chemistry and received his Ph.D. in organic chemistry from the University of California, San Diego as a DuPont pharmaceuticals fellow and has additional training in molecular pharmacology from Stanford University.

Colleen Mauger, R.N.

Research Coordinator

Colleen studied nursing at Purdue University and started her clinical career as a Registered Nurse working in the Intensive Care Unit for over thirteen years. She has extensive experience working with critically ill patients and gained experience treating patients with a wide range of degenerative diseases including Alzheimer’s disease, Diabetes, and Parkinson’s disease with a specific focus on cardiac and stroke patients.

Colleen was trained in many lifesaving devices such as LVAD’s, PRISMA’s and Therapeutic Hypothermia among many others. In addition to patient care, she also served as a charge nurse, nursing preceptor, and electronic medical records educator to hospital physicians. Colleen has additional training as a Legal Nurse Consultant working alongside attorneys on a diverse array of medically-related legal issues with extensive experience in debilitating neurological injuries such as traumatic brain injury.

Colleen’s clinical experience aligns well with Neurodon’s therapeutic pipeline.